“Specifically Targeting Interleukin-13 With Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients With Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s9. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/1162.